Exosome delivery CasRx gene silencing AAV vector and construction method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- THE SECOND PEOPLES HOSPITAL OF SHENZHEN
- Publication Date
- 2021-06-25
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention relates to the field of gene technology, in particular to an AAV vector for delivery of CasRx gene silencing by exosomes and its construction method and application. Background technique
[0002] On March 16, 2018, a major achievement published in the journal "Cell" brought a big leap forward in RNA editing technology. Scientists from the Salk Institute in the United States expanded the RNA editing ability with a new CRISPR family enzyme, and Name this new system "CasRx." A key feature of the new system, in addition to its high efficiency and absence of apparent off-target effects, is its reliance on an enzyme that is physically smaller than in previous studies. This is crucial for RNA editing technology, which makes it easier for the editing tool to be packaged into a viral vector and enter cells for RNA editing. Hiroshi Nishimasu, a scientist at the University of Tokyo who was not involved in the study, said: "In this study, the resea...